FDA 483 - EMSI - December 08, 2022

EMSI, a Spec Developer in Tampa, FL, was inspected by the FDA from December 5-8, 2022. The inspection revealed deficiencies in the firm's quality system, specifically regarding finished device acceptance procedures and employee training. These issues indicate a lack of adherence to established protocols for device manufacturing and personnel competency.